| 产品描述: | Ponatinib (AP24534) hydrochloride is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively |
| 靶点: |
VEGFR2:1.5 nM (IC50);FGFR1:2.2 nM (IC50);PDGFRα:1.1 nM (IC50);Abl:0.37 nM (IC50);LYN:0.24 nM (IC50);Src:5.4 nM (IC50) |
| 体内研究: |
Ponatinib hydrochloride (溶解于 25 mM 柠檬酸缓冲液 (pH 2.75) 中,体积 200 μL, 口服) 通过抑制细胞因子风暴保护小鼠免受致命流感感染。 |
| 参考文献: |
1. O'Hare T, et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell, 2009, 16(5), 401-412. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.757 ml |
8.787 ml |
17.574 ml |
| 5 mM |
0.351 ml |
1.757 ml |
3.515 ml |
| 10 mM |
0.176 ml |
0.879 ml |
1.757 ml |
| 50 mM |
0.035 ml |
0.176 ml |
0.351 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |